Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 17, 2026, Ana Hooker notified the Board of Directors (the “Board”) of Exagen Inc. (the “Company”) of her decision to resign as member of the Board, including all committees thereof, effective April 17, 2026 ("Effective Time"). Ms. Hooker was a member of the Audit Committee and chair of the Nominating and Corporate Governance Committee. Her decision to resign was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The size of the Board was decreased from eight (8) members to seven (7) members, effective as of the Effective Time.
As of the Effective Time, following the resignation described above, the Committees of the Board will be as follows:
Name of Director
Audit
Compensation
Nominating and Corporate Governance
Paul Kim †
X
X
Scott D. Kahn, Ph.D.
X
C
Tina S. Nova, Ph.D.
Bruce C. Robertson, Ph.D.
X
X
Frank Stokes †
C
X
Charles McKhann
X
C
C Committee Chairman
† Financial ExpertXGN Exagen Inc. - 8-K
Accession
0001274737-26-0000155.029.01
Item 5.02 - Departure/Election of Directors or Certain Officers
185 words
Item 9.01 - Financial Statements and Exhibits
23 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)